Patents by Inventor CLAIRE DENAULT
CLAIRE DENAULT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220257956Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: ApplicationFiled: May 9, 2022Publication date: August 18, 2022Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Patent number: 11400302Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.Type: GrantFiled: October 30, 2020Date of Patent: August 2, 2022Assignee: Shiratronics, Inc.Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
-
Patent number: 11357995Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: GrantFiled: May 29, 2020Date of Patent: June 14, 2022Assignee: Shiratronics, Inc.Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Publication number: 20210046319Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.Type: ApplicationFiled: October 30, 2020Publication date: February 18, 2021Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
-
Patent number: 10850112Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.Type: GrantFiled: February 6, 2018Date of Patent: December 1, 2020Assignee: NUXCEL, INC.Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
-
Publication number: 20200289833Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: ApplicationFiled: May 29, 2020Publication date: September 17, 2020Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Patent number: 10695571Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: GrantFiled: February 9, 2018Date of Patent: June 30, 2020Assignee: NUXCEL, INC.Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Publication number: 20180236245Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: ApplicationFiled: February 9, 2018Publication date: August 23, 2018Inventors: HARRY DELLAMANO, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, MICHAEL STEVEN COLVIN, PAUL GRIFFITH, FRANCIS MENEZES
-
Publication number: 20180221664Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.Type: ApplicationFiled: February 6, 2018Publication date: August 9, 2018Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER, MICHAEL STEVEN COLVIN, CLAIRE DENAULT
-
Patent number: 9889308Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: GrantFiled: January 9, 2017Date of Patent: February 13, 2018Assignee: Syntilla Medical LLCInventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Patent number: 9884190Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.Type: GrantFiled: October 9, 2015Date of Patent: February 6, 2018Assignee: Syntilla Medical LLCInventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
-
Patent number: 9839777Abstract: An implantable peripheral neurostimulation lead for head pain is adapted for implantation in the head for the therapeutic purpose of treating chronic head and/or face pain. The lead may include a lead body, a plurality of internal electrically conducting metal wires individually connecting to a proximal surface contact and a distal surface electrode; a distal extended metal surface electrode array; and a proximal in-line connector. The lead may be operable to provide medically acceptable therapeutic neurostimulation to multiple regions of the head, including the frontal, parietal, and occipital regions of the head simultaneously. The lead may include a supraorbital electrode array with electrodes of 3 to 5 mm in length spaced apart at 4 to 6 mm intervals. The lead may also include a temporal electrode array with electrodes of 4 to 6 mm in length spaced apart at 8 to 12 mm intervals.Type: GrantFiled: July 28, 2016Date of Patent: December 12, 2017Assignee: Syntilla Medical LLCInventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
-
Publication number: 20170113054Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: ApplicationFiled: January 9, 2017Publication date: April 27, 2017Inventors: HARRY DELLAMANO, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, MICHAEL STEVEN COLVIN, PAUL GRIFFITH, FRANCIS MENEZES
-
Patent number: 9539432Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: GrantFiled: January 7, 2016Date of Patent: January 10, 2017Assignee: Syntilla Medical LLCInventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Patent number: 9498636Abstract: A method is provided for controlling power delivery from an external power transfer system (EPTS) to at least one implantable neurostimulator system (INS). The method comprises driving a first transmit coil within the EPTS using a transmit coil driver circuit, receiving, using a receive coil, power transferred from the first transmit coil, coupling the received power to a regulator circuit, monitoring the regulator circuit, communicating a message to the EPTS using a back telemetry circuit, receiving the message, and adjusting the transmit coil driver circuit.Type: GrantFiled: January 7, 2016Date of Patent: November 22, 2016Assignee: SYNTILLA MEDICAL LLCInventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Patent number: 9498635Abstract: An implantable head-mounted, radiofrequency (RF) coupled, unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multiple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes (SME), which may be subdivided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the SME. The IPG may include an RF receiver coil and an application specific integrated circuit. The IPG may be capable of functional connection to an external RF unit for purposes that may include power, diagnostics, and programming.Type: GrantFiled: January 6, 2016Date of Patent: November 22, 2016Assignee: SYNTILLA MEDICAL LLCInventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
-
Publication number: 20160331953Abstract: An implantable peripheral neurostimulation lead for head pain is adapted for implantation in the head for the therapeutic purpose of treating chronic head and/or face pain. The lead may include a lead body, a plurality of internal electrically conducting metal wires individually connecting to a proximal surface contact and a distal surface electrode; a distal extended metal surface electrode array; and a proximal in-line connector. The lead may be operable to provide medically acceptable therapeutic neurostimulation to multiple regions of the head, including the frontal, parietal, and occipital regions of the head simultaneously. The lead may include a supraorbital electrode array with electrodes of 3 to 5 mm in length spaced apart at 4 to 6 mm intervals. The lead may also include a temporal electrode array with electrodes of 4 to 6 mm in length spaced apart at 8 to 12 mm intervals.Type: ApplicationFiled: July 28, 2016Publication date: November 17, 2016Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER, MICHAEL STEVEN COLVIN, CLAIRE DENAULT
-
Publication number: 20160114177Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.Type: ApplicationFiled: January 7, 2016Publication date: April 28, 2016Inventors: Michael Steven Colvin, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Harry Dellamano, Paul Griffith, Francis Menezes
-
Publication number: 20160114175Abstract: A method is provided for controlling power delivery from an external power transfer system (EPTS) to at least one implantable neurostimulator system (INS). The method comprises driving a first transmit coil within the EPTS using a transmit coil driver circuit, receiving, using a receive coil, power transferred from the first transmit coil, coupling the received power to a regulator circuit, monitoring the regulator circuit, communicating a message to the EPTS using a back telemetry circuit, receiving the message, and adjusting the transmit coil driver circuit.Type: ApplicationFiled: January 7, 2016Publication date: April 28, 2016Inventors: MICHAEL STEVEN COLVIN, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, HARRY DELLAMANO, PAUL GRIFFITH, FRANCIS MENEZES
-
Publication number: 20160114174Abstract: An implantable head-mounted, radiofrequency (RF) coupled, unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multiple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes (SME), which may be subdivided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the SME. The IPG may include an RF receiver coil and an application specific integrated circuit. The IPG may be capable of functional connection to an external RF unit for purposes that may include power, diagnostics, and programming.Type: ApplicationFiled: January 6, 2016Publication date: April 28, 2016Inventors: Michael Steven Colvin, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Harry Dellamano, Paul Griffith, Francis Menezes